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Over January the news has indicated that
the EU and US are to take different
approaches to semi and nano futures. 
For the EU, the route is to be through
NanoCMOS (budget possibly <$100m).
The aim to build ‘a CMOS backbone for
2010 e-Europe.’ First phase is to produce a
SRAM chip by 2005, followed in 2006 by
focus on 32nmand 22nm nodes. At that point
Medea Plus (the extension of Medea
which put STM, Philips & Infineon into top
chip ranking and boosted ASML and oth-
ers into winning as equipment suppliers)
will work on 45nm technologies in the
300mm wafer environment. 
Also new, a Si-Nano network is to link up
the best EU academic researchers to plan
R&D for Nano-CMOS needs.
For the US, however, the driving goal is
nano. Its National Science Foundation
(NSF) has created a 13 member National
Nanotechnology Infrastructure Network -
for the world’s largest and most accessible
nanoscale laboratory. Funding at $70m or
higher for five years, with a possible five
year renewal, the consortium numbers
Cornell, Georgia IOT, Harvard, Howard,
PennState, Stanford, California SB,
Michigan, Minnesota, New Mexico, Texas
at Austin, Washington and Seattle univer-
sities, as well as Triangle National
Lithographic Center and the three NSF
facilities, Cornell Centers for Materials
Research, Nanoscale Systems and
Nanobiotechnology.
Figures on government committed invest-
ment in nanotech show EU at $450m, USA
at $710m, but Asia dominating at $970m.
Semiconductors, both compound and sili-
con for the US however, seem not to be a
focus. The Semiconductor Roadmap may
be throwing up road blocks, but the well
established US industry is to be left to find
its own solutions, with nimble assistance
from DARPA. 
And possibly many of the solutions will
emerge from thinking outside the box on
the Nano route. 
The only other area where the NSF is
showing preoccupation is with its Major
Research Equipment & Facilities Construc-
tion Roadmap over the next two decades. 
A report mandated by the US National
Academy of Sciences, chaired by Princeton
physics Professor, William Brinkman is to
offset the NSF’s ‘ad hoc and subjective’
spending on such projects as optical tele-
scopes or high energy particle accelerators. 
Albeit only 4% of NSF’s proposed 2004
$5.5bn budget, the facilities’ multimillion
dollar costs and potential to shape future
R&D makes for high visibility. NAS propos-
es peer reviews, ranking these, assessing
them against national goals, then select-
ing them in what is described as a “road
maps with off-ramps, not beltways.”
Interesting to see if the EU and US semi-
conductor approaches do have off-ramps,
or are instead beltways.
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